Training program for Specialist Pharmacist of Ambulatory Cancer Chemotherapy based on the renewal of Amended Pharmaceuticals and Medical Devices Law

株式会社薬事日報社から許諾を受けて、株式会社シーエムプラスが英語に翻訳しております。
オリジナルの正式言語は日本語であり、内容および解釈については日本語が優先されます。
With permission from Yakuji Nippo, Limited, CM Plus Corporation translated into English.
The original article is authored in Japanese, and the Japanese shall prevail in meaning in terms of content and interpretation.

Training program for "Specialist Pharmacist of Ambulatory Cancer Chemotherapy" based on the renewal of Amended Pharmaceuticals and Medical Devices Law
Japanese Society of Pharmaceutical Oncology (JAPSO)
October 7th, 2020

Japanese Society of Pharmaceutical Oncology (JAPSO) will start the new system to certify pharmacists as "Specialist Pharmacist of Ambulatory Cancer Chemotherapy" under the Amended Pharmaceuticals and Medical Devices Law. The new system will respond to establishing a "pharmacy that collaborates with specialized medical institutions" in August next year. The critical point is that pharmacists who work in pharmacy must experience on-the-job training in cancer clinics. The training model will be held this year, and next year the real training will begin. Hiroyoshi Kato, the chief director said, "To meet social needs, it becomes easier even for pharmacist at individual pharmacy to participate. I hope many people can acquire the certification."

■ For pharmacies, start in April next year
In response to the Amended Pharmaceuticals and Medical Devices Law, JAPSO has been considering supporting the establishment of "pharmacy that collaborates with specialized medical institutions" since last fall. Based on the current "Accredited Pharmacist of Ambulatory Cancer Chemotherapy," it was decided to establish the new system for a specialist pharmacist with the addition of on-the-job training as a new requirement.

(Continue to the next)

For this translated article in English, CM Plus Corporation shall have the copyright. Unauthorized reproduction of posted articles, photos, diagrams, etc. is prohibited.
Copyright © 2020 LSMIP office / CM Plus Singapore Pte. Ltd.